HR 9 $25 mil. cost/benefit analysis trigger is "unreasonably low" --GOP dissent.
This article was originally published in The Tan Sheet
Executive Summary
HR 9 $25 MIL. COST/BENEFIT ANALYSIS TRIGGER "UNREASONABLY LOW" given the provision's analytic requirements, three Republican members of the House Science Committee assert in "supplemental" majority views contained in a committee report on HR 9 published Feb. 15. Title III of the "Job Creation and Wage Enhancement Act" (HR 9) would require a cost/benefit analysis for regulations with an annual effect on the economy of $25 mil. or more.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning